Bio-Techne (TECH) Short-term Investments (2010 - 2024)
Bio-Techne (TECH) posted quarterly Short-term Investments of $1.1 million for Q2 2024, down 95.48% year-over-year from $23.7 million in Q3 2023, and down 80.14% quarter-over-quarter from $5.4 million in Q1 2024.
Analysis
Bio-Techne (TECH) Short-term Investments (2010 - 2024) Analysis & Trends
Bio-Techne's Short-term Investments history runs 15 years deep, the most recent figure standing at $1.1 million for Q2 2024.
- In Q2 2024, Short-term Investments fell 95.48% year-over-year to $1.1 million; the TTM figure through Jun 2024 stood at $1.1 million (down 95.48% YoY), while the FY2024 annual figure was $1.1 million, down 95.48% from the prior year.
- Short-term Investments for Q2 2024 stood at $1.1 million, down from $5.4 million in the prior quarter.
- The five-year high for Short-term Investments was $124.3 million in Q2 2020, with the low at $1.1 million in Q2 2024.
- The 5-year median for Short-term Investments is $38.7 million (2021), against an average of $57.3 million.
- The sharpest annual moves came in 2022 and 2024: Short-term Investments soared 129.37% in 2022, then plunged 95.48% in 2024.
- Bio-Techne's Short-term Investments stood at $117.4 million in 2020, then sank by 42.83% to $67.1 million in 2021, then plunged by 52.22% to $32.1 million in 2022, then plunged by 82.79% to $5.5 million in 2023, then tumbled by 80.58% to $1.1 million in 2024.
- Business Quant data shows TECH's Short-term Investments at $1.1 million in Q2 2024, $5.4 million in Q1 2024, and $5.5 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 5.40 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Jun 30, 2023 | 23.74 Mn |
| Mar 31, 2023 | 29.92 Mn |
| Dec 31, 2022 | 32.07 Mn |
| Sep 30, 2022 | 37.82 Mn |
| Jun 30, 2022 | 74.46 Mn |
| Mar 31, 2022 | 70.35 Mn |
| Dec 31, 2021 | 67.14 Mn |
| Sep 30, 2021 | 38.74 Mn |
| Jun 30, 2021 | 32.46 Mn |
| Mar 31, 2021 | 90.11 Mn |
| Dec 31, 2020 | 117.43 Mn |
| Sep 30, 2020 | 117.99 Mn |
| Jun 30, 2020 | 124.27 Mn |
| Mar 31, 2020 | 104.87 Mn |
| Dec 31, 2019 | 133.66 Mn |
| Sep 30, 2019 | 58.52 Mn |
| Jun 30, 2019 | 65.15 Mn |